Cargando…
Medication-induced weight gain and advanced therapies for the child with overweight and obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement 2022
BACKGROUND: This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) details medication-induced weight gain and advanced therapies for the child with overweight or obesity. METHODS: The scientific information and clinical guidance in this CPS are based on scientific evidence, suppor...
Autores principales: | Cuda, Suzanne, Censani, Marisa, Kharofa, Roohi, O'Hara, Valerie, Conroy, Rushika, Williams, Dominique R., Paisley, Jennifer, Browne, Allen F., Karjoo, Sara, Browne, Nancy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662101/ https://www.ncbi.nlm.nih.gov/pubmed/37990664 http://dx.doi.org/10.1016/j.obpill.2022.100048 |
Ejemplares similares
-
Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022
por: Cuda, Suzanne, et al.
Publicado: (2022) -
Metabolic, behavioral health, and disordered eating comorbidities associated with obesity in pediatric patients: An Obesity Medical Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne E., et al.
Publicado: (2022) -
Corrigendum to “Social consequences and genetics for the child with overweight and obesity: An obesity medicine association (OMA) clinical practice statement 2022” [Obes. Pillars 3 (2022) 100032]
por: Cuda, Suzanne, et al.
Publicado: (2022) -
Clinical review: Guide to pharmacological management in pediatric obesity medicine
por: O'Hara, Valerie, et al.
Publicado: (2023) -
Assessment, differential diagnosis, and initial clinical evaluation of the pediatric patient with obesity: An Obesity Medical Association (OMA) Clinical Practice Statement 2022
por: Cuda, Suzanne E., et al.
Publicado: (2022)